We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Australian Court Bars Ranbaxy’s Generic Lipitor

Law360 (December 19, 2006, 12:00 AM EST) -- In another blow to generic drug maker Ranbaxy Laboratories, the Australian Federal Court has upheld the exclusivity of Pfizer Inc.’s patent covering an active ingredient in anti-cholesterol drug Lipitor in Australia....
To view the full article, register now.